Ranking Invest

FUSN - Fusion Pharmaceuticals Inc.

Segmento: HealthcareFusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.

Análise Ranking Invest

Valuation estimado
-$ 97.13 Mi
Valor de Mercado
$ 1.83 Bi
Desconto (AV)-1987.2%
MLL
-0.18A companhia gerou lucro líquido equivalente a -18% do seu valor de mercado nos últimos 4 trimestres.
Último Balanço Atualizado: 1T2024

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 241.83 Mi

Dívida Líquida

$ 36.29 Mi

L4T

-$ 104.28 Mi

MM4T

-18746.98%

Indicadores Básicos

ROE

-43.12%

Índices de Previsibilidade

Faturamento

0.98

Lucro

0.25

Margem

0.96

Índices de Tendência

Faturamento

4.23

Lucro

-2.12

Margem

-4.21

Índices de Endividamento

DIV/PAT

0.15

DIV/L4T

-0.35

Dívidas
Cotação
Gráfico Lucro/Faturamento X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.